A Chinese mRNA COVID vaccine gets its first approval — in Indonesia

COVID-19: Indonesia approves emergency use of China’s mRNA vaccine - Peoples Gazette

The vaccine prevents infection with the SARS CoV-2 virus in individuals aged 18 years and above, as a primary and heterologous booster dose.

A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia

JAKARTA/BEIJING -- Indonesia said it has granted emergency use approval to an mRNA COVID-19 vaccine developed by a Chinese company, becoming the first country, ahead of even China, to do so. Read More

A Chinese MRNA COVID Vaccine Is Approved For The First Time - In Indonesia

The approval comes as somewhat of a surprise as Walvax has yet to publish efficacy readings that would show how well it can reduce the risk of COVID cases and deaths.

Indonesia approves first homegrown COVID-19 vaccine

JAKARTA — Indonesia has approved its first locally developed COVID-19 vaccine for emergency use, the head of the country's public health agency said Friday, hailing it as a step toward

China's first mRNA COVID-19 vaccine obtains approval in Indonesia

The Indonesian food and drugs agency (BPOM) has approved a China-developed mRNA COVID-19 vaccine by granting it an Emergency Use Approval (EUA) for people aged 18 and above, according to its press release on Friday.The shot, previously known as ARCoV,

Indonesia approves first homegrown Covid-19 vaccine

IndoVac jab granted halal certificate; public health agency head says vaccine has shown efficacy rate of 92pc.